Drug intelligence / Profile preview

Nerkardou

Development stage
Unknown
Lead developer
Nerhadou International
Modality
Small Molecules
Administration
Oral
01

Overview

Nerkardou is an oral dissolvable film (ODF) formulation of bisoprolol fumarate, a selective beta-1 adrenergic receptor antagonist. Developed by Nerhadou International and studied by the Genuine Research Center in Egypt, it is indicated for the treatment of essential hypertension. The drug is delivered via a thin film that dissolves rapidly on the tongue without the need for water, offering a convenient and discreet administration method that may enhance patient adherence. By selectively blocking beta-1 receptors in the heart, bisoprolol reduces heart rate and cardiac output, effectively lowering blood pressure. It is currently being evaluated in the Phase IV BETTER trial to assess its safety, efficacy, and compliance in Egyptian patients.

Brand names
Nerkardou
Other names
Bisoprolol oral dissolvable filmBisoprolol ODF
02

Targets

ADRB1 (β1)

Beyond the preview

Go deeper on Nerkardou.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerkardou.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call